Spectinomycin: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Barry Canton (talk | contribs) No edit summary |
Barry Canton (talk | contribs) No edit summary |
||
| Line 9: | Line 9: | ||
==Inhibiting protein synthesis== | ==Inhibiting protein synthesis== | ||
In addition to being used for selection, spectinomycin can also be used to inhibit protein synthesis, for example, in the | In addition to being used for selection, spectinomycin can also be used to inhibit protein synthesis, for example, to inhibit wild-type ribosome activity in the presence of orthogonal ribosomes. Papers using spectinomycin in this way include - | ||
<biblio> | <biblio> | ||
#Rackham pmid = 16408021 | #Rackham pmid=16408021 | ||
#Brink pmid=7758959 | |||
</biblio> | </biblio> | ||
[[Category:Material]] [[Category:Antibiotic]] | [[Category:Material]] [[Category:Antibiotic]] | ||
Revision as of 12:38, 2 September 2007
Mode of Action
Spectinomycin is a bacteriostatic agent that inhibits translocation of the peptidyl tRNA from the A site to the P site.
Working Concentrations and Stock Solutions
Up to 100mg/mL stock concentration. 100ug/mL final concentration.
Resistance Gene
Mutations in rpsE, the S5 protein, prevent spectinomycin from binding.
Inhibiting protein synthesis
In addition to being used for selection, spectinomycin can also be used to inhibit protein synthesis, for example, to inhibit wild-type ribosome activity in the presence of orthogonal ribosomes. Papers using spectinomycin in this way include -
- Rackham O and Chin JW. A network of orthogonal ribosome x mRNA pairs. Nat Chem Biol. 2005 Aug;1(3):159-66. DOI:10.1038/nchembio719 |
- Brink MF, Verbeet MP, and de Boer HA. Specialized ribosomes: highly specific translation in vivo of a single targetted mRNA species. Gene. 1995 Apr 24;156(2):215-22. DOI:10.1016/0378-1119(95)00030-a |
